| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-966-01 | 59651-966 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 800 mg/1 | 100 TABLET in 1 BOTTLE (59651-966-01) |
| 59651-966-05 | 59651-966 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 800 mg/1 | 500 TABLET in 1 BOTTLE (59651-966-05) |
| 59651-966-10 | 59651-966 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 800 mg/1 | 10 TABLET in 1 BOTTLE (59651-966-10) |
| 59651-965-01 | 59651-965 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 400 mg/1 | 100 TABLET in 1 BOTTLE (59651-965-01) |
| 59651-965-05 | 59651-965 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 400 mg/1 | 500 TABLET in 1 BOTTLE (59651-965-05) |
| 59651-965-10 | 59651-965 | HUMAN PRESCRIPTION DRUG | ACYCLOVIR | ACYCLOVIR | TABLET | ORAL | 20250911 | N/A | ANDA | ANDA075211 | Aurobindo Pharma Limited | ACYCLOVIR | 400 mg/1 | 10 TABLET in 1 BOTTLE (59651-965-10) |